Clinical Pharmacokinetics and Pharmacodynamics of Infliximab in the Treatment of Inflammatory Bowel Disease
出版年份 2018 全文链接
标题
Clinical Pharmacokinetics and Pharmacodynamics of Infliximab in the Treatment of Inflammatory Bowel Disease
作者
关键词
-
出版物
CLINICAL PHARMACOKINETICS
Volume 57, Issue 8, Pages 929-942
出版商
Springer Nature
发表日期
2018-01-12
DOI
10.1007/s40262-017-0627-0
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- American Gastroenterological Association Institute Technical Review on the Role of Therapeutic Drug Monitoring in the Management of Inflammatory Bowel Diseases
- (2017) Niels Vande Casteele et al. GASTROENTEROLOGY
- American Gastroenterological Association Institute Guideline on Therapeutic Drug Monitoring in Inflammatory Bowel Disease
- (2017) Joseph D. Feuerstein et al. GASTROENTEROLOGY
- Clinical relevance of detecting anti-infliximab antibodies with a drug-tolerant assay: post hoc analysis of the TAXIT trial
- (2017) Thomas Van Stappen et al. GUT
- A Real-life Population Pharmacokinetic Study Reveals Factors Associated with Clearance and Immunogenicity of Infliximab in Inflammatory Bowel Disease
- (2017) Johannan F. Brandse et al. INFLAMMATORY BOWEL DISEASES
- Systematic review with meta-analysis: loss of response and requirement of anti-TNFα dose intensification in Crohn’s disease
- (2017) Yun Qiu et al. JOURNAL OF GASTROENTEROLOGY
- Application of Population Pharmacokinetic Modeling for Individualized Infliximab Dosing Strategies in Crohn Disease
- (2017) Adam Frymoyer et al. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
- Infliximab Optimization Based on Therapeutic Drug Monitoring in Pediatric Inflammatory Bowel Disease
- (2017) Tatyana Hofmekler et al. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
- Current Practices for Therapeutic Drug Monitoring of Biopharmaceuticals in Pediatrics
- (2017) Sara Murias et al. THERAPEUTIC DRUG MONITORING
- Comparisons of Serum Infliximab and Antibodies-to-Infliximab Tests Used in Inflammatory Bowel Disease Clinical Trials of Remicade®
- (2016) Joseph C. Marini et al. AAPS Journal
- A Genetic Variation in the Neonatal Fc-Receptor Affects Anti-TNF Drug Concentrations in Inflammatory Bowel Disease
- (2016) Thomas Billiet et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Pharmacokinetic Features and Presence of Antidrug Antibodies Associate With Response to Infliximab Induction Therapy in Patients With Moderate to Severe Ulcerative Colitis
- (2016) Johannan F. Brandse et al. Clinical Gastroenterology and Hepatology
- Infliximab Concentration Thresholds During Induction Therapy Are Associated With Short-term Mucosal Healing in Patients With Ulcerative Colitis
- (2016) Konstantinos Papamichael et al. Clinical Gastroenterology and Hepatology
- Validation of a sample pretreatment protocol to convert a drug-sensitive into a drug-tolerant anti-infliximab antibody immunoassay
- (2016) Thomas Van Stappen et al. Drug Testing and Analysis
- Infliximab Dosing Strategies and Predicted Trough Exposure in Children With Crohn Disease
- (2016) Adam Frymoyer et al. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
- The underlying inflammatory chronic disease influences infliximab pharmacokinetics
- (2016) Christophe Passot et al. mAbs
- Immunogenicity to Biotherapeutics – The Role of Anti-drug Immune Complexes
- (2016) Murli Krishna et al. Frontiers in Immunology
- Review article: pharmacological aspects of anti-TNF biosimilars in inflammatory bowel diseases
- (2015) K. Papamichael et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
- (2015) L Peyrin-Biroulet et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- A Panel to Predict Long-term Outcome of Infliximab Therapy for Patients With Ulcerative Colitis
- (2015) Maria Theresa Arias et al. Clinical Gastroenterology and Hepatology
- Trough Concentrations of Infliximab Guide Dosing for Patients With Inflammatory Bowel Disease
- (2015) Niels Vande Casteele et al. GASTROENTEROLOGY
- Loss of Infliximab Into Feces Is Associated With Lack of Response to Therapy in Patients With Severe Ulcerative Colitis
- (2015) Johannan F. Brandse et al. GASTROENTEROLOGY
- Antibodies to Infliximab Are Associated with Lower Infliximab Levels and Increased Likelihood of Surgery in Pediatric IBD
- (2015) Naamah L. Zitomersky et al. INFLAMMATORY BOWEL DISEASES
- Extraintestinal Manifestations of Inflammatory Bowel Disease
- (2015) Stephan R. Vavricka et al. INFLAMMATORY BOWEL DISEASES
- Pharmacokinetics of anti-TNF monoclonal antibodies in inflammatory bowel disease: Adding value to current practice
- (2015) Niels Vande Casteele et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Infliximab-Related Infusion Reactions: Systematic Review
- (2015) Lev Lichtenstein et al. Journal of Crohns & Colitis
- Inflammatory bowel disease pathogenesis: Where are we?
- (2015) Claudio Fiocchi JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- The association of infliximab trough levels with disease activity in pediatric inflammatory bowel disease
- (2015) Daniël R. Hoekman et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Inflammatory Bowel Disease in Children and Adolescents
- (2015) Michael J. Rosen et al. JAMA Pediatrics
- Association Between Serum Concentration of Infliximab and Efficacy in Adult Patients With Ulcerative Colitis
- (2014) Omoniyi J. Adedokun et al. GASTROENTEROLOGY
- Postinduction serum infliximab trough level and decrease of C-reactive protein level are associated with durable sustained response to infliximab: a retrospective analysis of the ACCENT I trial
- (2014) Freddy Cornillie et al. GUT
- Patient Factors That Increase Infliximab Clearance and Shorten Half-life in Inflammatory Bowel Disease
- (2014) Iris Dotan et al. INFLAMMATORY BOWEL DISEASES
- A 10-Year, Single Tertiary Care Center Experience on the Durability of Infliximab in Pediatric Inflammatory Bowel Disease
- (2014) Elaheh Vahabnezhad et al. INFLAMMATORY BOWEL DISEASES
- Infliximab Maintains Durable Response and Facilitates Catch-up Growth in Luminal Pediatric Crohnʼs Disease
- (2014) Peter C. Church et al. INFLAMMATORY BOWEL DISEASES
- Proactive Therapeutic Concentration Monitoring of Infliximab May Improve Outcomes for Patients with Inflammatory Bowel Disease
- (2014) Byron P. Vaughn et al. INFLAMMATORY BOWEL DISEASES
- Early Infliximab Trough Levels Are Associated with Persistent Remission in Pediatric Patients with Inflammatory Bowel Disease
- (2014) Namita Singh et al. INFLAMMATORY BOWEL DISEASES
- Treatment of complex perianal fistulas with seton and infliximab in adolescents with Crohn's disease
- (2014) Maria Hukkinen et al. Journal of Crohns & Colitis
- Antibody Response to Infliximab and its Impact on Pharmacokinetics can be Transient
- (2013) Niels Vande Casteele et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Long-term measurement of anti-adalimumab using pH-shift-anti-idiotype antigen binding test shows predictive value and transient antibody formation
- (2013) Pauline A van Schouwenburg et al. ANNALS OF THE RHEUMATIC DISEASES
- Relationship between inflammation and infliximab pharmacokinetics in rheumatoid arthritis
- (2013) David Ternant et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Individualised therapy is more cost-effective than dose intensification in patients with Crohn’s disease who lose response to anti-TNF treatment: a randomised, controlled trial
- (2013) Casper Steenholdt et al. GUT
- The temporal evolution of antidrug antibodies in patients with inflammatory bowel disease treated with infliximab
- (2013) Bella Ungar et al. GUT
- Therapeutic Drug Monitoring of Infliximab and Mucosal Healing in Inflammatory Bowel Disease
- (2013) Stephane Paul et al. INFLAMMATORY BOWEL DISEASES
- Pharmacokinetics of Infliximab in Children with Moderate-to-Severe Ulcerative Colitis
- (2013) Omoniyi J. Adedokun et al. INFLAMMATORY BOWEL DISEASES
- Challenges in Designing a National Surveillance Program for Inflammatory Bowel Disease in the United States
- (2013) Millie D. Long et al. INFLAMMATORY BOWEL DISEASES
- Antibodies to Infliximab and Risk of Infusion Reactions in Patients With Inflammatory Bowel Disease
- (2013) Sorcha O’Meara et al. INFLAMMATORY BOWEL DISEASES
- Monitoring of adalimumab and antibodies-to-adalimumab levels in patient serum by the homogeneous mobility shift assay
- (2013) Shui-Long Wang et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Anti-TNF Monoclonal Antibodies in Inflammatory Bowel Disease: Pharmacokinetics-Based Dosing Paradigms
- (2012) I Ordás et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Monoclonal antibodies: what are the pharmacokinetic and pharmacodynamic considerations for drug development?
- (2012) Rong Deng et al. Expert Opinion on Drug Metabolism & Toxicology
- Development and validation of a homogeneous mobility shift assay for the measurement of infliximab and antibodies-to-infliximab levels in patient serum
- (2012) Shui-Long Wang et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Assessing Response and Loss of Response to Biological Therapies in IBD
- (2011) Henit Yanai et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Levels of C-reactive Protein Are Associated With Response to Infliximab Therapy in Patients With Crohn's Disease
- (2011) Matthias Jürgens et al. Clinical Gastroenterology and Hepatology
- Pharmacokinetic Properties of Infliximab in Children and Adults with Crohn's Disease: A Retrospective Analysis of Data from 2 Phase III Clinical Trials
- (2011) Adedigbo A. Fasanmade et al. CLINICAL THERAPEUTICS
- Therapeutic Drug Monitoring of Biologics for Inflammatory Bowel Disease
- (2011) Jean-Frédéric Colombel et al. INFLAMMATORY BOWEL DISEASES
- Serum albumin concentration: a predictive factor of infliximab pharmacokinetics and clinical response in patients with ulcerative colitis
- (2011) A.A. Fasanmade et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Infliximab therapy in children with Crohn’s disease: a one-year evaluation of efficacy comparing ‘top-down’ and ‘step-up’ strategies
- (2010) Mi Jin Kim et al. ACTA PAEDIATRICA
- Appropriate infliximab infusion dosage and monitoring: results of a panel meeting of rheumatologists, dermatologists and gastroenterologists
- (2010) Hilbert S. De Vries et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Prospective Evaluation of Anti-Tumor Necrosis Factor Therapy Guided by Magnetic Resonance Imaging for Crohn's Perineal Fistulas
- (2009) Siew C Ng et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- TNF-alpha gene expression in colorectal mucosa as a predictor of remission after induction therapy with infliximab in ulcerative colitis
- (2009) Trine Olsen et al. CYTOKINE
- Population pharmacokinetic analysis of infliximab in patients with ulcerative colitis
- (2009) Adedigbo A. Fasanmade et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Trough serum infliximab: a predictive factor of clinical outcome for infliximab treatment in acute ulcerative colitis
- (2009) C H Seow et al. GUT
- Incidence and clinical significance of immunogenicity to infliximab in Crohnʼs disease
- (2009) Andrea Cassinotti et al. INFLAMMATORY BOWEL DISEASES
- Infliximab Therapy in Children With Concurrent Perianal Crohn Disease: Observations From REACH
- (2009) Wallace Crandall et al. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
- Monoclonal Antibody Pharmacokinetics and Pharmacodynamics
- (2008) W Wang et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Efficacy of Infliximab in Pediatric Crohnʼs Disease: A Randomized Multicenter Open-Label Trial Comparing Scheduled to On Demand Maintenance Therapy
- (2008) Frank M. Ruemmele et al. INFLAMMATORY BOWEL DISEASES
- Tumor necrosis factor antagonist mechanisms of action: A comprehensive review
- (2007) Daniel Tracey et al. PHARMACOLOGY & THERAPEUTICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started